6.
Liu Y, Wu C, Ko P, Chien S, Fan N, Wang H
. Mycobacterial infections in adult recipients of allogeneic hematopoietic stem cell transplantation: A cohort study in a high endemic area. J Microbiol Immunol Infect. 2018; 53(2):274-282.
DOI: 10.1016/j.jmii.2018.07.001.
View
7.
Yoo J, Jo K, Kim S, Lee S, Kim J, Park S
. Incidence, characteristics, and treatment outcomes of mycobacterial diseases in transplant recipients. Transpl Int. 2016; 29(5):549-58.
DOI: 10.1111/tri.12752.
View
8.
Munoz L, Santin M
. Prevention and Management of Tuberculosis in Transplant Recipients: From Guidelines to Clinical Practice. Transplantation. 2016; 100(9):1840-52.
DOI: 10.1097/TP.0000000000001224.
View
9.
Yoo J, Lee D, Choi S, Choi J, Park Y, Kim Y
. Infectious complications and outcomes after allogeneic hematopoietic stem cell transplantation in Korea. Bone Marrow Transplant. 2004; 34(6):497-504.
DOI: 10.1038/sj.bmt.1704636.
View
10.
Bergeron A, Mikulska M, De Greef J, Bondeelle L, Franquet T, Herrmann J
. Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in Leukaemia. Lancet Infect Dis. 2022; 22(12):e359-e369.
DOI: 10.1016/S1473-3099(22)00227-4.
View
11.
Al-Anazi K, Al-Jasser A, Evans D
. Infections caused by mycobacterium tuberculosis in patients with hematological disorders and in recipients of hematopoietic stem cell transplant, a twelve year retrospective study. Ann Clin Microbiol Antimicrob. 2007; 6:16.
PMC: 2200647.
DOI: 10.1186/1476-0711-6-16.
View
12.
Ku S, Tang J, Hsueh P, Luh K, Yu C, Yang P
. Pulmonary tuberculosis in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001; 27(12):1293-7.
DOI: 10.1038/sj.bmt.1703092.
View
13.
High W, Evans C, Hoang M
. Cutaneous miliary tuberculosis in two patients with HIV infection. J Am Acad Dermatol. 2004; 50(5 Suppl):S110-3.
DOI: 10.1016/j.jaad.2003.09.020.
View
14.
Trubiano J, Dickinson M, Thursky K, Spelman T, Seymour J, Slavin M
. Incidence, etiology and timing of infections following azacitidine therapy for myelodysplastic syndromes. Leuk Lymphoma. 2017; 58(10):2379-2386.
DOI: 10.1080/10428194.2017.1295141.
View
15.
de la Camara R, Martino R, Granados E, Rovira M, Cabrera R, Lopez J
. Tuberculosis after hematopoietic stem cell transplantation: incidence, clinical characteristics and outcome. Spanish Group on Infectious Complications in Hematopoietic Transplantation. Bone Marrow Transplant. 2000; 26(3):291-8.
DOI: 10.1038/sj.bmt.1702506.
View
16.
Cheng M, Kusztos A, Bold T, Ho V, Glotzbecker B, Hsieh C
. Risk of Latent Tuberculosis Reactivation After Hematopoietic cell Transplantation. Clin Infect Dis. 2019; 69(5):869-872.
PMC: 6938207.
DOI: 10.1093/cid/ciz048.
View
17.
Singh N
. Unique Rarity of Tuberculosis and Granulomatous Opportunistic Infections in Hematopoietic Cell Transplant Recipients. Clin Infect Dis. 2019; 71(2):470-471.
DOI: 10.1093/cid/ciz979.
View
18.
Aki S, Sucak G, Tunccan O, Kokturk N, Senol E
. The incidence of tuberculosis infection in hematopoietic stem cell transplantation recipients: A retrospective cohort study from a center in Turkey. Transpl Infect Dis. 2018; 20(4):e12912.
DOI: 10.1111/tid.12912.
View
19.
Budak-Alpdogan T, TANGUN Y, Kalayoglu-Besisik S, Ratip S, Akan H, Baslar Z
. The frequency of tuberculosis in adult allogeneic stem cell transplant recipients in Turkey. Biol Blood Marrow Transplant. 2000; 6(4):370-4.
DOI: 10.1016/s1083-8791(00)70013-9.
View
20.
Maeda T, Kusumi E, Kami M, Kawabata M, Le Pavoux A, Hara S
. Disseminated tuberculosis following reduced-intensity cord blood transplantation for adult patients with hematological diseases. Bone Marrow Transplant. 2004; 35(1):91-7.
DOI: 10.1038/sj.bmt.1704740.
View